1st Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Period 1st Quarter 2009 Filed Apr 20, 2009 Signed by Cristin Lis, Senior Director, Government Affairs

Official filing
Firm
GILEAD SCIENCES, INC.
Client
GILEAD SCIENCES INC
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International Trade Issues; Global Health Issues; FDA Globalization Act; Domestic HIV Policy Issues (eg. H.R. 1943-Stop AIDS in Prison Act; H.R. 822 - Routine HIV/AIDS Screening Coverage Act; H.R. 6114, S 2969 - Simplifying and Updating National Standards to Encourage Testing of the HIV Act; Ryan White Program Reauthorization Act; Enhanced FMAP for routine HIV screening.); Sunshine Act

LobbyistCovered position, as disclosed
CRISTIN LIS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 822 (111th), H.R. 1943 (111th), H.R. 6114 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.